CEL-SCI Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cost of Revenue	15.89	18.16	22.47	25.36	23.11
Gross Profit	-15.89	-18.16	-22.47	-25.36	-23.11
Selling, General & Admin	8.92	8.19	9	10.71	13.09
Operating Expenses	8.92	8.19	9	10.71	13.09
Operating Income	-24.81	-26.35	-31.48	-36.06	-36.19
Interest Expense	-0.65	-0.75	-0.68	-1.08	-1.13
Other Non Operating Income (Expenses)	0.05	-0.48	-0.21	-0.46	-1.08
EBT Excluding Unusual Items	-25.41	-27.58	-32.37	-37.6	-38.4
Gain (Loss) on Sale of Investments	-	-	-	-	1.69
Asset Writedown	-	-	-	-0.03	-
Pretax Income	-25.41	-27.58	-32.37	-37.63	-36.71
Net Income	-25.41	-27.58	-32.37	-37.63	-36.71
Net Income to Common	-25.41	-27.58	-32.37	-37.63	-36.71
Shares Outstanding (Basic)	4	2	1	1	1
Shares Outstanding (Diluted)	4	2	1	1	1
Shares Change (YoY)	125.13%	21.52%	3.08%	6.03%	10.71%
EPS (Basic)	-6.27	-15.31	-21.83	-26.17	-27.09
EPS (Diluted)	-6.27	-15.31	-21.83	-26.17	-27.87
Free Cash Flow	-17.16	-18.91	-23.21	-18.88	-27.8
Free Cash Flow Per Share	-4.23	-10.49	-15.66	-13.13	-20.50
EBITDA	-22.72	-24.18	-29.32	-34.03	-33.96
D&A For EBITDA	2.09	2.17	2.16	2.03	2.23
EBIT	-24.81	-26.35	-31.48	-36.06	-36.19

Updated Dec 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q